A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
13 11 2023
13 11 2023
Historique:
received:
06
07
2023
accepted:
09
11
2023
medline:
15
11
2023
pubmed:
14
11
2023
entrez:
13
11
2023
Statut:
epublish
Résumé
Hepatitis B is a risk factor for the development of intrahepatic cholangiocarcinoma. The prognosis of HBV-related ICC remains to be further investigated. To investigate the clinical, pathological and imaging features of intrahepatic cholangiocarcinoma of hepatitis B virus-positive and -negative patients. Data from January 31, 2012 to December 31, 2019 of 138 patients were retrospectively analyzed. The patients were divided into hepatitis B virus-positive group (group A[n = 66]) and virus-negative group (group B[n = 72]), and the patients were divided into groups according to pathological differentiation degree and tumor size. The differences in clinical, imaging characteristics and the progression-free survival between groups were analyzed. There were significant differences in gender, age, HBc antibody, CA125 and AFP, tumor distribution site, maximum diameter, plain scan density, inferior hepatic angle, peritumoral bile duct dilatation, vascular encasement invasion, intrahepatic bile duct dilatation and lymphadenopathy between the two groups (P < 0.05); There were statistical differences in signs of vascular encasement invasion between the two groups with well-to-moderately differentiated tumors (P < 0.05); there were statistical differences in tumor density uniformity, signs of vascular encasement invasion and lymphadenopathy between the two groups with poorly differentiated tumors (P < 0.05). Large groups A and B showed differences in tumor density uniformity, vascular encasement invasion, arterial phase, overall reinforcement pattern, peritumoral bile duct stones and biliary dilatation (P < 0.05). There was no statistical difference in postoperative PFS between the two groups (P > 0.05). The clinical and imaging features of ICC of hepatitis B virus-positive and -negative patients are different, and there is little difference in postoperative disease-free survival time.
Identifiants
pubmed: 37957323
doi: 10.1038/s41598-023-47108-6
pii: 10.1038/s41598-023-47108-6
pmc: PMC10643568
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
19726Informations de copyright
© 2023. The Author(s).
Références
Clin Infect Dis. 2012 Jan 1;54(1):88-90
pubmed: 22052888
Hepatology. 2019 Apr;69(4):1803-1815
pubmed: 30251463
Curr Oncol. 2022 Jan 30;29(2):698-723
pubmed: 35200560
Liver Cancer. 2022 Feb 23;11(4):290-314
pubmed: 35978598
Infect Agent Cancer. 2022 Aug 27;17(1):45
pubmed: 36030232
J Hepatol. 2018 Apr;68(4):655-662
pubmed: 29155069
J Viral Hepat. 2013 May;20(5):306-10
pubmed: 23565611
World J Gastroenterol. 2016 Mar 14;22(10):3038-51
pubmed: 26973400
Hepatol Int. 2018 Jul;12(4):330-338
pubmed: 29947010
ANZ J Surg. 2018 Mar;88(3):212-217
pubmed: 27598539
J Hepatol. 2013 Jun;58(6):1188-93
pubmed: 23485522
BMC Cancer. 2021 Dec 5;21(1):1299
pubmed: 34863147
PLoS Pathog. 2019 May 23;15(5):e1007818
pubmed: 31121000
Hepatology. 2022 Apr;75(4):997-1011
pubmed: 34478159
Histopathology. 2020 Jan;76(2):182-188
pubmed: 31433515
Hepatology. 2019 Aug;70(2):547-562
pubmed: 30325540
Ann Surg Oncol. 2017 Jun;24(6):1579-1587
pubmed: 28058554
J Magn Reson Imaging. 2016 Nov;44(5):1330-1338
pubmed: 27087012
Gut. 2022 Aug;71(8):1669-1683
pubmed: 35580963
CA Cancer J Clin. 2023 Mar;73(2):198-222
pubmed: 36260350
Eur J Cancer. 2010 Apr;46(6):1056-61
pubmed: 20202823
Oncotarget. 2017 Mar 7;8(10):17292-17300
pubmed: 28030846
Front Cell Infect Microbiol. 2023 Jan 25;13:1082390
pubmed: 36761898
J Natl Compr Canc Netw. 2021 May 1;19(5):541-565
pubmed: 34030131
Int J Biol Markers. 2018 Nov;33(4):432-438
pubmed: 29874985
Radiographics. 2022 Sep-Oct;42(5):1320-1337
pubmed: 35930475
Hepatobiliary Pancreat Dis Int. 2022 Oct;21(5):472-478
pubmed: 35948505
Int J Cancer. 2023 Mar 15;152(6):1107-1114
pubmed: 36196489
World J Gastroenterol. 2011 Mar 14;17(10):1292-303
pubmed: 21455328
Hepatology. 2018 Apr;67(4):1560-1599
pubmed: 29405329
Radiology. 2019 Mar;290(3):691-699
pubmed: 30620253
Zhonghua Gan Zang Bing Za Zhi. 2019 Oct 20;27(10):748-753
pubmed: 31734987
J Hepatol. 2022 May;76(5):1109-1121
pubmed: 35167909
J Surg Oncol. 2010 Mar 1;101(3):233-8
pubmed: 20169539
Nat Rev Dis Primers. 2021 Sep 9;7(1):65
pubmed: 34504109
Radiology. 2017 Mar;282(3):771-781
pubmed: 27797675
J Surg Oncol. 2019 Jan;119(1):40-46
pubmed: 30480811
J Gastroenterol. 2022 May;57(5):387-395
pubmed: 35357571
Korean J Intern Med. 2020 May;35(3):566-573
pubmed: 31916422